Physician Adherence to Fondaparinux Prescribing Information for Patients with Superficial Vein Thrombosis (SVT) of the Lower Limbs (115280)

Study identification

• EU PAS number:
  EUPAS6655
• Study ID:
  42081
• Official title and acronym:
  Physician Adherence to Fondaparinux Prescribing Information for Patients with Superficial Vein Thrombosis (SVT) of the Lower Limbs (115280)
• DARWIN EU® study:
  No
• Study countries:
  Germany

  Greece

  Slovenia
• Study status:
  Finalised

Research institutions and networks

Institutions

GlaxoSmithKline (GSK)

Study timelines

Date when funding contract was signed

Planned:23/10/2012

Actual:23/10/2012

Study start date

Planned:23/10/2012

Actual:23/10/2012

Date of final study report

Planned:30/09/2014

Actual:26/08/2014

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

GlaxoSmithKline

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)